The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: A comparison with bezafibrate

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 25, Issue 6, 2010, Pages 751-755

  Shattat, Ghassan ^a   Al Qirim, Tariq ^a   Sweidan, Kamal ^a   Shahwan, Moyad ^a   El Huneidi, Waseem ^a   Al Hiari, Yusuf ^b  

^a AL ZAYTOONAH UNIVERSITY OF JORDAN   (Jordan)

^b UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Benzofuran 2 carboxamide; High density lipoprotein cholesterol; Hypolipidemic activity; Triglycerides; Triton WR 1339 induced hyperlipidemic rats

Indexed keywords

AMIDE; ANTILIPEMIC AGENT; BEZAFIBRATE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; N (4 BENZOYLPHENYL)BENZOFURAN 2 CARBOXAMIDE; N (9,10 DIHYDRO 9,10 DIOXOANTHRACEN 2 YL)BEZOFURAN 2 CARBOXAMIDE; TRIACYLGLYCEROL; TYLOXAPOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HYPERLIPIDEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTHRACENES; ATHEROSCLEROSIS; BENZOFURANS; BEZAFIBRATE; CHOLESTEROL; CHOLESTEROL, HDL; DETERGENTS; DRUG DESIGN; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MOLECULAR STRUCTURE; POLYETHYLENE GLYCOLS; RANDOM ALLOCATION; RATS; RATS, WISTAR; TIME FACTORS; TRIGLYCERIDES;

ANIMALIA; RATTUS;

EID: 78149451332     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756360903389880     Document Type: Article

References (26)

1. Epstein FM. The hepatorenal syndrome-newer perspectives. N Engl J Med 1992;327:1774-8.
2. Libby P, Schoenbeck U, Mach F, Selwyn AP, Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med 1998;104:18S-27S.
3. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 1986;2:933-6.
4. West KM, Ahuja MS, Bennet PH. The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983;6: 361-9.
5. Schurr PE, Schultz JR, Parkinson TM. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids 1972;7:69-74.
6. Hayashi H, Niinobe S, Matsumoto Y, Suga T. Effects of Triton WR-1339 on lipoprotein lipolytic activity and lipid content of rat liver lysosomes. J Biochem 1981;89:573-9.
7. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-45.
8. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410-18.
9. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferatoractivated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996;37:907-25.
10. Ross BC, Middlemiss D, Scopes D, Jack T, Cardwell K, Dowle M, et al. Benzofuran derivatives. US Patent 5498722, May 15, 1992.
11. Holzemann G, Schiemann K, Bottcher H, Heinrich T, Seyfried C, Leibrock J, et al. Benzofuran oxyethylamines as antidepressants and anxiolytics. US Patent 7425574, September 16, 2008.
12. Parker RA. Alkoxy benzofuran carboxylic acids and salts and esters thereof as hypolipidemic agents. US Patent 4229467, October 21, 1980.
13. Sohda T, Odaka H, Momose Y. Benzofuran compounds and their use. US Patent 5723479, March 3, 1998.
14. Kellner A, Correll JW, Ladd AT. The influence of intravenously administered surface-active agents on the development of experimental atherosclerosis in rabbits. J Exp Med 1951;93:385-98.
15. Ohmori K, Yamada H, Yasuda A, Yamamoto A, Matsuura N, Kiniwa M. Effects of a novel anti-hyperlipidemic agent, S-2E, on blood lipid levels in rats with fructose-induced hypertriglyceridemia. Pharmacology 2004;72:240-6.
16. Harnafi H, Bouanani N, Aziz M, Serghini H, Ghalim N, Amrani S. The hypolipidaemic activity of aqueous Erica multiflora flowers extract in Triton WR-1339 induced hyperlipidaemic rats: a comparison with fenofibrate. J Ethnopharmacol 2007;109:156-60.
17. Lauk L, Galati EM, Forestieri AM, Kirjavainen S, Trovato A. Mucuma pruriens infusion lowers cholesterol and total lipid plasma levels in the rat. Phytother Res 1989;3:263-4.
18. Khanna AK, Chauder R, Chandan S, Srivastava AK, Kapoor NK. Hypolipidemic activity of Achyranthus aspera Linn in normal and Triton induced hyperlipemic rats. Indian J Exp Biol 1992;30:128-30.
19. Yamamoto K, Byrne R, Edelstein C, Shen B, Scanu AM. In vitro effect of Triton WR-1339 on canine plasma high density lipoproteins. J Lipid Res 1984;25:770-9.
20. Otway S, Robinson DS. The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J Physiol 1967;190:309-19.
21. Campillo JE, Torres MD, Dominguez E, Romero A, Perez C. Ficus carica leaf administration reduces hypertrygliceridaemia in streptozotocin diabetic rats. Diabetologia 1994;37:A213.
22. Perez C, Canal JR, Campello JE, Adelaida R, Torres MD. Hypotriglyceridaemic activity of Ficus carica leaves in experimental hypertriglyceridaemic rats. Phytother Res 1999;13:188-91.
23. Khanna AK, Rizvi F, Chander R. Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. J Ethnopharmacol 2002;82:19-22.
24. Malloy MJ, Kan JP. Medical management of hyperlipidemic states. Adv Intern Med 1994;39:603-31.
25. Anila L, Vijayalakshmi NR. Flavonoids from Emblica officinalis and Mangifera indicia - effectiveness for dyslipidemia. J Ethnopharmacol 2002;79:81-7.
26. Staels B, Dallongville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998;98:2088-93.